Article

Adjuvant Tamoxifen for 10 Years Better Than 5 Years in ER-Positive Breast Cancer

Author(s):

Bonnie Gillis

Extending the duration of adjuvant tamoxifen treatment to 10 years was more effective than the standard 5 years of treatment in protecting against recurrence and death among women with ER+ breast cancer.

Extending the duration of adjuvant tamoxifen treatment to 10 years was more effective than the standard 5 years of treatment in protecting against recurrence and death among women with ER+ breast cancer.

Click here to view the full-text version of this article.

Related Videos
Crisis Point: Benzene Concerns in Acne Care
4 experts are featured in this series.
4 experts are featured in this series.
Experts' Perspectives: Top Stories in Cardiology for 2024
Related Content
Richard B. Lipton, MD I Credit: Albert Einstein College of Medicine
December 24th 2024

Atogepant 60 mg Demonstrates Superior to Placebo for Migraine by Day 1

Chelsie Derman
Site Logo
December 23rd 2024

Navigating Lifestyle and Pharmacotherapy Interventions in Dyslipidemia Management

Pam R. Taub, MD, FACC, FASPC Marc P. Bonaca, MD, MPH
Darren Brenner, MD | Credit: Northwestern Medicine
December 24th 2024

Tenapanor Improves Abdominal Symptoms Independent of Bowel Symptoms in IBS-C

Abigail Brooks, MA
Video: Exploring Bempedoic Acid: Clinical Indications, Efficacy, and Future Directions in Cardiovascular Risk Management
December 17th 2024

Video: Exploring Bempedoic Acid: Clinical Indications, Efficacy, and Future Directions in Cardiovascular Risk Management

Pam R. Taub, MD, FACC, FASPC Marc P. Bonaca, MD, MPH
Credit: Adobe Stock/ Onephoto
December 23rd 2024

Greater Non-HDL/HDL Cholesterol Ratio Linked to Lower Anemia Rates

Chelsie Derman
You-Lin Tain, MD, PhD | Credit: ResearchGate
December 23rd 2024

Use of Ibuprofen, Other NSAIDs During Pregnancy Could Increase Risk of Childhood CKD

Abigail Brooks, MA
© 2024 MJH Life Sciences

All rights reserved.